Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Ministerio de Ciencia, Innovación y Universidades (España); Consejo Superior de Investigaciones Científicas (España); Comunidad de Madrid
    • بيانات النشر:
      American Chemical Society
    • الموضوع:
      2023
    • Collection:
      Digital.CSIC (Consejo Superior de Investigaciones Científicas / Spanish National Research Council)
    • نبذة مختصرة :
      GPR55 is an orphan G-protein coupled receptor involved in various pathophysiological conditions. However, there are only a few noncannabinoid GPR55 ligands reported so far. The lack of potent and selective GPR55 ligands precludes a deep exploration of this receptor. The studies presented here focused on a thienopyrimidine scaffold based on the GPR55 antagonist ML192, previously discovered by high-throughput screening. The GPR55 activities of the new synthesized compounds were assessed using β-arrestin recruitment assays in Chinese hamster ovary cells overexpressing human GPR55. Some derivatives were identified as GPR55 antagonists with functional efficacy and selectivity versus CB1 and CB2 cannabinoid receptors. ; M.E.A., P.H.R., and N.J. are supported by National Institutes of Health grant R01 DA0455698. M.E.A. and P.Z. thank the financial support NIH P30 DA013429. P.M. and N.J. are supported by the Ministry of Science, Innovation, and Universities, Spain (MCIU)/FEDER grant RTI2018-095544-B-I00 and the Spanish National Research Council (CSIC) grant PIE-201580E033. P.M. acknowledges the Comunidad de Madrid (CM) programme “Atraccion de Talento” number 2018-T2/BMD-10819 and “Juan de la Cierva Incorporación Programme-MICIU” (IJC 2019-042182-I)
    • ISSN:
      1948-5875
    • Relation:
      #PLACEHOLDER_PARENT_METADATA_VALUE#; info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-095544-B-I00/ES/ABORDAJE DE LAS ENFERMEDADES CRONICAS CON NUEVOS ENFOQUES TERAPEUTICOS PARA MODULAR EL SISTEMA ENDOCANNABINOIDE/; info:eu-repo/grantAgreement/AEI//PIE-201580E033; info:eu-repo/grantAgreement//CM/2018-T2/BMD-10819; info:eu-repo/grantAgreement/AEI//IJC 2019-042182-I; Publisher's version; http://dx.doi.org/10.1021/acsmedchemlett.2c00325; Sí; ACS Medicinal Chemistry Letters 14: 18- 25 (2023); http://hdl.handle.net/10261/309060
    • الرقم المعرف:
      10.1021/acsmedchemlett.2c00325
    • الدخول الالكتروني :
      http://hdl.handle.net/10261/309060
      https://doi.org/10.1021/acsmedchemlett.2c00325
    • Rights:
      open
    • الرقم المعرف:
      edsbas.7EBE267C